Publications by authors named "Li-Jie Mi"
Background: Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia in critically ill patients and significantly impacts mortality. This study sought to evaluate the impact of new-onset AF on mortality in a critically ill population.
Methods: This study identified 48018 adult patients admitted to the ICU from the Medical Information Mart for Intensive Care (MIMIC)-IV database.
Background: The interplay between atrial fibrillation (AF) and obesity on mortality in critically ill patients warrants detailed exploration, given their individual impacts on patient prognosis. This study aimed to assess the associations between AF, obesity, and 1-year mortality in a critically ill population.
Methods: Utilizing data from the Medical Information Mart for Intensive Care (MIMIC)-IV database, we conducted a retrospective analysis of adult patients admitted to the intensive care unit.
Background: Semaglutide, a glucagon-like peptide-1 receptor agonist, is reported to have cardiac benefits, but its effects on preventing atrial fibrillation (AF) remain inconclusive. This study aimed to investigate whether semaglutide can prevent AF occurrence in patients with type 2 diabetes mellitus (T2DM), obesity, or overweight.
Methods: We searched MEDLINE, EMBASE, the Cochrane CENTRAL database, and clinicaltrials.
Activation pattern of the coronary sinus facilitates the differentiation for ventricular outflow tract arrhythmias.
J Cardiovasc Electrophysiol
July 2024
Introduction: The accuracy of surface ECG algorithms for predicting the origin of outflow tract ventricular arrhythmias (OT-VAs) might be questioned. Intracardiac electrograms recorded at anatomic landmarks could provide new predictive insights. We aim to evaluate the efficacy of a novel criterion utilizing the activation pattern of the coronary sinus (CS) in localizing OT-VAs, including VAs originating from the right ventricular outflow tract (RVOT), endocardial left ventricular outflow tract (Endo-LVOT), and epicardial left ventricular outflow tract (Epi-LVOT).
View Article and Find Full Text PDFArticle Synopsis
- The study investigated whether SGLT2 inhibitors can reduce the occurrence of atrial fibrillation (AF) in patients with cardiometabolic diseases, finding inconclusive results.
- A comprehensive review of 46 randomized, placebo-controlled trials involving over 101,000 patients showed no significant risk reduction for AF with SGLT2 inhibitors, despite a slight favorable trend.
- The results were consistent across different types and doses of SGLT2 inhibitors and across varied patient groups, concluding that these medications do not lower AF occurrence risk among those with cardiometabolic issues.
Background: The vein of Marshall (VOM) ethanol infusion improves rhythm control in atrial fibrillation (AF). The identification and cannulation of the VOM can be technically challenging. This study aimed to assess the angiographic morphology of the VOM and investigate its value in the VOM ethanol infusion.
View Article and Find Full Text PDFBackground: The vein of Marshall (VOM) ethanol infusion is increasingly performed in combination with catheter ablation in atrial fibrillation (AF). The cannulation of the VOM can sometimes be challenging. This study aimed to evaluate the double-wire technique in cases of difficult cannulation of the VOM.
View Article and Find Full Text PDFBackground: Electrocardiogram (ECG) abnormalities indicating right ventricular strain have been reported to have prognostic value in severe cases of acute pulmonary embolism (PE). We aimed to analyze the prognostic significance of other quantitative ECG parameters in non-high-risk acute PE.
Methods: Consecutive patients with non-high-risk acute PE were prospectively enrolled.